Minimal sex-differential modulation of reactivity to pathogens and toll-like receptor ligands following infant Bacillus Calmette–Guérin Russia vaccination
Bacillus Calmette–Guérin (BCG), the only licensed vaccine against tuberculosis, has been shown to provide heterologous protection against unrelated pathogens and enhance antibody responses to several routine expanded program on immunization (EPI) vaccines. Understanding these heterologous effects is...
Main Authors: | Darboe, F, Adetifa, JU, Reynolds, J, Hossin, S, Plebanski, M, Netea, MG, Rowland-Jones, SL, Sutherland, JS, Flanagan, KL |
---|---|
פורמט: | Journal article |
יצא לאור: |
Frontiers Media
2017
|
פריטים דומים
-
Minimal Sex-Differential Modulation of Reactivity to Pathogens and Toll-Like Receptor Ligands following Infant Bacillus Calmette–Guérin Russia Vaccination
מאת: Fatoumatta Darboe, et al.
יצא לאור: (2017-09-01) -
Reiter's syndrome postintravesical Bacillus Calmette–Guérin instillations
מאת: Ng, K.L., et al.
יצא לאור: (2017) -
Bacillus Calmette–Guérin Immunotherapy for Cancer
מאת: Fabíola Cardillo, et al.
יצא לאור: (2021-05-01) -
Bacillus Calmette–Guérin and Bladder Cancer
מאת: Azad H.A. Razack
יצא לאור: (2007-10-01) -
Hepatitis in Disseminated Bacillus Calmette-Guérin Infection
מאת: Markus U Göttke, et al.
יצא לאור: (2000-01-01)